"This is not a drill," says Erin Gibbs when talking about 2026 being "the year" for small and mid-cap stocks. She explains what makes the coming year different from past bullish expectations which experienced head fakes. Erin's top picks include Krystal Biotech (KRYS), Exelixis (EXEL), and Neurocrine (NBIX).